189 related articles for article (PubMed ID: 25197384)
41. Lung adenocarcinomas with micropapillary components.
Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Tokuyasu H; Kawasaki Y
Gen Thorac Cardiovasc Surg; 2009 Oct; 57(10):534-9. PubMed ID: 19830516
[TBL] [Abstract][Full Text] [Related]
42. Role of cytoblock on pleural effusion for diagnosis of malignant disease.
Shahini L; Hoxha M; Marku F; Morina B; Cena V; Kabashi K; Mustafa L
Diagn Cytopathol; 2023 Nov; 51(11):684-688. PubMed ID: 37547992
[TBL] [Abstract][Full Text] [Related]
43. Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma.
Zhao ZR; Lau RWH; Long H; Mok TSK; Chen GG; Underwood MJ; Ng CSH
J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2310-2318.e2. PubMed ID: 30180981
[TBL] [Abstract][Full Text] [Related]
44. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
45. Normal Tumor Markers and Increased Adenosine Deaminase in Pericardial Effusion Misdiagnosed as Tuberculous Pericarditis Ultimately Proven as Lung Adenocarcinoma with Pericardial Metastasis: a Case Report and Literature Review.
Ge YL; Liu CH; Zhang Q; Gao HS; Wang YM; Chen Y; Li WQ; Chen QC; Zhu XY; Jin JJ; Xu TT; Fu AS
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115232
[TBL] [Abstract][Full Text] [Related]
46. Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells.
Lee HJ; Eom DW; Kang GH; Han SH; Cheon GJ; Oh HS; Han KH; Ahn HJ; Jang HJ; Han MS
Mod Pathol; 2013 Aug; 26(8):1123-31. PubMed ID: 23060121
[TBL] [Abstract][Full Text] [Related]
47. Cytodiagnostic aspects of lung adenocarcinoma manifesting with micropapillary pattern in sputum: a case report of potential diagnostic pitfall.
Chang NY; Wang J; Lin CC; Chen SW
Diagn Cytopathol; 2014 Oct; 42(10):902-5. PubMed ID: 24554565
[TBL] [Abstract][Full Text] [Related]
48. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.
Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S
Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745
[TBL] [Abstract][Full Text] [Related]
49. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
50. The importance of an ECG: back to basics.
Haidari G; Gray K; Kirubakaran S
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23192583
[TBL] [Abstract][Full Text] [Related]
51. miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology.
Cappellesso R; Galasso M; Nicolè L; Dabrilli P; Volinia S; Fassina A
Cancer Cytopathol; 2017 Aug; 125(8):635-643. PubMed ID: 28449331
[TBL] [Abstract][Full Text] [Related]
52. Cytological features of metastatic ceruminous adenocarcinoma (not otherwise specified) in pleural effusion: A case report.
Lan Z; Li J; Yang F
Cytopathology; 2021 May; 32(3):360-363. PubMed ID: 33184923
[No Abstract] [Full Text] [Related]
53. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
54. Ber-EP4 staining in effusion cytology: A potential source of false positives.
Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ
Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887
[TBL] [Abstract][Full Text] [Related]
55. [Thoracocentesis for the assessment of lung cancer with pleural effusion].
Martín Díaz E; Arnau Obrer A; Martorell Cebollada M; Cantó Armengod A
Arch Bronconeumol; 2002 Oct; 38(10):479-84. PubMed ID: 12372198
[TBL] [Abstract][Full Text] [Related]
56. Malignant pleural and pericardial effusion in invasive breast cancer: impact of the site of the primary tumor.
Pokieser W; Cassik P; Fischer G; Vesely M; Ulrich W; Peters-Engl C
Breast Cancer Res Treat; 2004 Jan; 83(2):139-42. PubMed ID: 14997044
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
Kim M; Chung YS; Kim KA; Shim HS
Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.
Zhang J; Liang Z; Gao J; Luo Y; Liu T
Histopathology; 2011 Dec; 59(6):1204-14. PubMed ID: 22175900
[TBL] [Abstract][Full Text] [Related]
59. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
60. The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic malignancies in pericardial effusions.
Gupta RK; Kenwright DN; Fauck R; Lallu S; Naran S
Cytopathology; 2000 Oct; 11(5):312-21. PubMed ID: 11014658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
